Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,277 | 40,560 | 49,901 | 46,790 | 62,285 |
| Receivables | 22,989 | 21,626 | 28,176 | 28,228 | 7,001 |
| Inventories | 16,558 | 16,314 | 16,339 | 16,576 | 6,571 |
| Other current assets | 1,418 | 1,195 | 1,038 | 1,615 | 10,599 |
| TOTAL | $87,540 | $89,038 | $105,234 | $100,013 | $92,538 |
| Non-Current Assets | |||||
| PPE Net | 4,294 | 4,666 | 5,140 | 5,558 | 90 |
| Intangibles | 127,688 | 129,734 | 151,266 | 162,039 | 73,789 |
| Other Non-Current Assets | 4,302 | 4,291 | 4,028 | 3,947 | 326 |
| TOTAL | $136,284 | $138,691 | $160,434 | $171,544 | $74,205 |
| Total Assets | $223,824 | $227,729 | $265,668 | $271,557 | $166,742 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 26,862 | 24,249 | 24,602 | 7,462 | 1,979 |
| Accounts payable and accrued liabilities | 15,604 | 9,383 | 19,255 | 16,529 | 7,157 |
| Accrued Expenses | 55,726 | 59,142 | 57,234 | 53,692 | 11,418 |
| Other current liabilities | 1,206 | 4,139 | 8,347 | 5,089 | 5,159 |
| TOTAL | $100,571 | $97,997 | $109,438 | $83,683 | $25,813 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,752 | 5,639 | 180 | 26,354 | 9,946 |
| Other Non-Current Liabilities | 12,965 | 12,593 | 18,482 | 18,371 | 18,290 |
| TOTAL | $17,717 | $18,232 | $18,662 | $44,724 | $28,236 |
| Total Liabilities | $118,288 | $116,229 | $128,100 | $128,407 | $54,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,516 | 1,407 | 1,378 | 1,259 | 894 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -217,698 | -206,150 | -178,299 | -159,301 | -133,841 |
| TOTAL | $105,536 | $111,500 | $137,568 | $143,150 | $112,693 |
| Total Liabilities And Equity | $223,824 | $227,729 | $265,668 | $271,557 | $166,742 |